Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 5
2008 2
2009 3
2010 3
2011 1
2013 3
2014 1
2015 1
2016 1
2018 1
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss JM, Yarnold JR; START Trialists' Group. Haviland JS, et al. Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19. Lancet Oncol. 2013. PMID: 24055415 Clinical Trial.
BACKGROUND: 5-year results of the UK Standardisation of Breast Radiotherapy (START) trials suggested that lower total doses of radiotherapy delivered in fewer, larger doses (fractions) are at least as safe and effective as the historical standard regimen (50 Gy in 25 fract …
BACKGROUND: 5-year results of the UK Standardisation of Breast Radiotherapy (START) trials suggested that lower total doses of radiot …
Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction.
Potter S, Trickey A, Rattay T, O'Connell RL, Dave R, Baker E, Whisker L, Skillman J, Gardiner MD, Macmillan RD, Holcombe C; TeaM and iBRA-2 Steering Groups, the Breast Reconstruction Research Collaborative, and the Mammary Fold Academic and Research Collaborative. Potter S, et al. Br J Surg. 2020 Jun;107(7):832-844. doi: 10.1002/bjs.11468. Epub 2020 Feb 19. Br J Surg. 2020. PMID: 32073654
BACKGROUND: Therapeutic mammaplasty (TM) may be an alternative to mastectomy, but few well designed studies have evaluated the success of this approach or compared the short-term outcomes of TM with mastectomy with or without immediate breast reconstruction (IBR). Data fro …
BACKGROUND: Therapeutic mammaplasty (TM) may be an alternative to mastectomy, but few well designed studies have evaluated the success of th …
Male breast cancer: a review of clinical management.
Agrawal A, Ayantunde AA, Rampaul R, Robertson JF. Agrawal A, et al. Breast Cancer Res Treat. 2007 May;103(1):11-21. doi: 10.1007/s10549-006-9356-z. Epub 2006 Oct 11. Breast Cancer Res Treat. 2007. PMID: 17033919 Review.
AIMS: Male breast cancer incidence is 1% of all breast cancers and is increasing. ...CONCLUSIONS: There is, thus, need for further increasing awareness among men to reduce stigma associated with presentation of symptoms related to breast. This should be in ad …
AIMS: Male breast cancer incidence is 1% of all breast cancers and is increasing. ...CONCLUSIONS: There is, thus, need for fur …
Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
Mathew J, Agrawal A, Asgeirsson KS, Buhari SA, Jackson LR, Cheung KL, Robertson JF. Mathew J, et al. Breast Cancer Res Treat. 2009 Jan;113(2):403-7. doi: 10.1007/s10549-008-9930-7. Epub 2008 Mar 2. Breast Cancer Res Treat. 2009. PMID: 18311583
INTRODUCTION: There are trials comparing different neoadjuvant chemotherapy regimens for locally advanced primary breast cancer (LAPC). Few studies have evaluated alternative therapeutic approaches towards LAPC. A previous trial from our institute in LAPC patients unselect …
INTRODUCTION: There are trials comparing different neoadjuvant chemotherapy regimens for locally advanced primary breast cancer (LAPC …
Esophagogastric cancers secondary to a breast primary tumor do not require resection.
Ayantunde AA, Agrawal A, Parsons SL, Welch NT. Ayantunde AA, et al. World J Surg. 2007 Aug;31(8):1597-601. doi: 10.1007/s00268-007-9099-y. World J Surg. 2007. PMID: 17578645 Review.
BACKGROUND: Breast cancer metastasis to the gastrointestinal tract (GIT) is rare. ...The use of systemic therapy for breast cancer may result in longer survival....
BACKGROUND: Breast cancer metastasis to the gastrointestinal tract (GIT) is rare. ...The use of systemic therapy for breast ca …
Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.
Mathew J, Asgeirsson KS, Agrawal A, Mukherjee A, Ellis IO, Cheung KL, Chan SY, Robertson JF. Mathew J, et al. Eur J Surg Oncol. 2007 Oct;33(8):972-6. doi: 10.1016/j.ejso.2007.02.005. Epub 2007 Mar 27. Eur J Surg Oncol. 2007. PMID: 17391905 Clinical Trial.
METHODS: Records of 50 consecutive patients receiving anthrcycline based chemotherapy for locally advanced breast cancers from July 1996 to July 2004 were analysed with regard to locoregional recurrence, metastasis and survival. ...The unit protocol for patients receiving …
METHODS: Records of 50 consecutive patients receiving anthrcycline based chemotherapy for locally advanced breast cancers from July 1 …
Combining clustering and classification ensembles: A novel pipeline to identify breast cancer profiles.
Agrawal U, Soria D, Wagner C, Garibaldi J, Ellis IO, Bartlett JMS, Cameron D, Rakha EA, Green AR. Agrawal U, et al. Artif Intell Med. 2019 Jun;97:27-37. doi: 10.1016/j.artmed.2019.05.002. Epub 2019 May 15. Artif Intell Med. 2019. PMID: 31202397
Breast Cancer is one of the most common causes of cancer death in women, representing a very complex disease with varied molecular alterations. To assist breast cancer prognosis, the classification of patients into biological groups is of great significance for trea
Breast Cancer is one of the most common causes of cancer death in women, representing a very complex disease with varied molecular al
Skin sparing mastectomy and immediate breast reconstruction: a review.
Agrawal A, Sibbering DM, Courtney CA. Agrawal A, et al. Eur J Surg Oncol. 2013 Apr;39(4):320-8. doi: 10.1016/j.ejso.2012.12.015. Epub 2013 Jan 17. Eur J Surg Oncol. 2013. PMID: 23333068 Review.
AIMS: Skin Sparing Mastectomy (SSM) is widely practised now in major centres which manage large numbers of breast cancer but anxiety still exists over the safety of SSM both from oncological and aesthetic points of view. ...RESULTS: There is abundance of evidence with rega …
AIMS: Skin Sparing Mastectomy (SSM) is widely practised now in major centres which manage large numbers of breast cancer but anxiety …
Overview of tyrosine kinase inhibitors in clinical breast cancer.
Agrawal A, Gutteridge E, Gee JM, Nicholson RI, Robertson JF. Agrawal A, et al. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S135-44. doi: 10.1677/erc.1.01059. Endocr Relat Cancer. 2005. PMID: 16113090 Review.
Such agents have proved promising in pre-clinical studies and are currently in clinical trials in breast cancer, where gefitinib has been studied more extensively to date. Here, we present an overview of the current development of gefitinib in clinical breast cancer …
Such agents have proved promising in pre-clinical studies and are currently in clinical trials in breast cancer, where gefitinib has …
Concepts of seroma formation and prevention in breast cancer surgery.
Agrawal A, Ayantunde AA, Cheung KL. Agrawal A, et al. ANZ J Surg. 2006 Dec;76(12):1088-95. doi: 10.1111/j.1445-2197.2006.03949.x. ANZ J Surg. 2006. PMID: 17199696 Review.
BACKGROUND: Seroma formation is the commonest early sequel to breast cancer surgery especially when axillary dissection is undertaken. ...RESULT: The pathophysiology and mechanism of seroma formation in breast cancer surgery remains controversial and not fully under …
BACKGROUND: Seroma formation is the commonest early sequel to breast cancer surgery especially when axillary dissection is undertaken …
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page